Kylei Dules, NP
Family · Sturgis, MINPI 1770303083
Payments from drug & device makers
Across 146 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$285
- AbbVie$282
- Novo Nordisk$272
- Vanda Pharmaceuticals Inc.$230
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$204
- Pfizer$203
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,773100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $285 |
| AbbVie | 17 | $282 |
| Novo Nordisk | 16 | $272 |
| Vanda Pharmaceuticals Inc. | 10 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $204 |
| Pfizer | 13 | $203 |
| Axsome Therapeutics, Inc. | 6 | $167 |
| Corcept Therapeutics | 12 | $162 |
| Bayer | 8 | $126 |
| Lundbeck LLC | 6 | $117 |
| Boehringer Ingelheim | 5 | $113 |
| Astellas Pharma US Inc | 4 | $101 |
| Madrigal Pharmaceuticals | 4 | $84 |
| Amgen | 5 | $82 |
| Lilly USA, LLC | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Biogen | 1 | $17 |
| Phadia US Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
How this compares
$2,773 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Sturgis
- Jade KlinglerSturgis$10K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.